Reporting scoping reviews—PRISMA ScR extension

Journal of Clinical Epidemiology

Volumn 123, Issue , 2020, Pages 177-179

  McGowan, Jessie ^a   Straus, Sharon ^b   Moher, David ^c   Langlois, Etienne V ^d   O'Brien, Kelly K ^e   Horsley, Tanya ^f   Aldcroft, Adrian ^g   Zarin, Wasifa ^b   Garitty, Chantelle Marie ^c   Hempel, Susanne ^h   Lillie, Erin ⁱ   Tunçalp, Ӧzge ^d   Tricco, Andrea C ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY OF TORONTO   (Canada)

^f ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA   (Canada)

^g BMA House ^*  (United Kingdom)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ Sunnybrook Health Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKLIST; DATA BASE; HUMAN; MEDICAL RESEARCH; NOTE; PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES; PRIORITY JOURNAL; PUBLICATION; SCIENTIFIC LITERATURE; LITERATURE; PRACTICE GUIDELINE; RESEARCH;

GUIDELINES AS TOPIC; HUMANS; RESEARCH REPORT; REVIEW LITERATURE AS TOPIC;

EID: 85083638527     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2020.03.016     Document Type: Note

References (31)

1. Glasziou, P., Meats, E., Heneghan, C., Shepperd, S., What is missing from descriptions of treatment in trials and reviews?. BMJ 336:7659 (2008), 1472–1474.
2. Hoffmann, T., English, T., Glasziou, P., Reporting of interventions in randomised trials: an audit of journal instructions to authors. Trials, 15, 2014, 20.
3. Simera, I., Moher, D., Hirst, A., Hoey, J., Schulz, K.F., Altman, D.G., Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med, 8, 2010, 24.
4. Song, F., Parekh, S., Hooper, L., Loke, Y.K., Ryder, J., Sutton, A.J., et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 14 (2010), 1–193.
5. Altman, D.G., Simera, I., Using reporting guidelines effectively to ensure good reporting of health research. Moher, D., Altman, D., Schulz, K., Simera, I., Wager, E., (eds.) Guidelines for Reporting Health Research: A User's Manual, 2014, J Wiley, Hoboken, NJ.
6. Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J., et al. (eds.) Cochrane Handbook for Systematic Reviews of Interventions version 6.0, 2019, Cochrane Available at www.training.cochrane.org/handbook. (Accessed 17 February 2020)
7. Aromataris, E., Munn, Z., Joanna Briggs Institute Reviewer's Manual. 2017, The Joanna Briggs Institute https://wiki.joannabriggs.org/display/MANUAL/JBI+Reviewer%27s+Manual. Accessed February 17, 2020.
8. Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in health care. 2009, Centre for Reviews and Dissemination, York Available at https://www.york.ac.uk/crd/SysRev/!SSL!/WebHelp/SysRev3.htm. (Accessed 17 February 2020)
9. Altman, D., Simera, I., Hoey, J., Moher, D., Schulz, K., EQUATOR: reporting guidelines for health research. Open Med, 2, 2008, e49.
10. Enhancing the QUAlity and transparency of health research (EQUATOR) network. Available at https://www.equator-network.org. (Accessed 7 February 2020)
11. Brouwers, M.C., Kerkvliet, K., Spithoff, K., The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ, 352, 2016, i1152.
12. Ogrinc, G., Davies, L., Goodman, D., Batalden, P., Davidoff, F., Stevens, D., SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf 25:12 (2016), 986–992.
13. IICoMJ. Preparing a Manuscript for Submission to a Medical Journal. Available at http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html, 2020. (Accessed 17 February 2020)
14. Zuniga-Hernandez, J.A., Dorsey-Trevino, E.G., Gonzalez-Gonzalez, J.G., Brito, J.P., Montori, V.M., Rodriguez-Gutierrez, R., Endorsement of reporting guidelines and study registration by endocrine and internal medicine journals: meta-epidemiological study. BMJ Open, 9(9), 2019, e031259.
15. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62 (2009), 1006–1012.
16. Tricco, A.C., Lillie, E., Zarin, W., O'Brien, K.K., Colquhoun, H., Levac, D., et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169 (2018), 467–473.
17. Welch, V., Petticrew, M., Petkovic, J., Moher, D., Waters, E., White, H., et al. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration. J Clin Epidemiol 70 (2016), 68–89.
18. Welch, V., Petticrew, M., Tugwell, P., Moher, D., O'Neill, J., Waters, E., et al. PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med, 9(10), 2012, e1001333.
19. Beller, E.M., Glasziou, P.P., Altman, D.G., Hopewell, S., Bastian, H., Chalmers, I., et al. PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med, 10(4), 2013, e1001419.
20. Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev, 4, 2015, 1.
21. Stewart, L.A., Clarke, M., Rovers, M., Riley, R.D., Simmonds, M., Stewart, G., et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA 313 (2015), 1657–1665.
22. Hutton, B., Salanti, G., Caldwell, D.M., Chaimani, A., Schmid, C.H., Cameron, C., et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162 (2015), 777–784.
23. Zorzela, L., Loke, Y.K., Ioannidis, J.P., Golder, S., Santaguida, P., Altman, D.G., et al. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ, 352, 2016, i157.
24. Guise, J.M., Butler, M.E., Chang, C., Viswanathan, M., Pigott, T., Tugwell, P., AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist. J Clin Epidemiol 90 (2017), 43–50.
25. McInnes, M.D.F., Moher, D., Thombs, B.D., McGrath, T.A., Bossuyt, P.M., Clifford, T., et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA 319 (2018), 388–396.
26. Tricco, A.C., Lillie, E., Zarin, W., O'Brien, K., Colquhoun, H., Kastner, M., et al. A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol, 16, 2016, 15.
27. Miake-Lye, I.M., Hempel, S., Shanman, R., Shekelle, P.G., What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products. Syst Rev, 5, 2016, 28.
28. Hoxha, M., A systematic review on the role of eicosanoid pathways in rheumatoid arthritis. Adv Med Sci 63 (2018), 22–29.
29. Bourne, A.M., Johnston, R.V., Cyril, S., Briggs, A.M., Clavisi, O., Duque, G., et al. Scoping review of priority setting of research topics for musculoskeletal conditions. BMJ Open, 8(12), 2018, e023962.
30. Solloway, M.R., Taylor, S.L., Shekelle, P.G., Miake-Lye, I.M., Beroes, J.M., Shanman, R.M., et al. An evidence map of the effect of Tai Chi on health outcomes. Syst Rev, 5, 2016, 126.
31. The PRISMA-ScR (PRISMA extention for scoping reviews). Available at https://knowledgetranslation.net/portfolios/the-prisma-scr-prisma-extension-for-scoping-reviews/, 2019. (Accessed 7 February 2020)